D&D Pharmatech Inc. (KOSDAQ:347850)

D&D Pharmatech Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-23,555	-28,623	3,934	-136,067	-68,224
Depreciation & Amortization	5,531	5,527	4,428	13,739	11,901
Loss (Gain) From Sale of Assets	0.13	118.38	84.78	-21,524	-
Asset Writedown & Restructuring Costs	-	9,199	-4,582	119,722	-
Loss (Gain) on Equity Investments	4,815	-1,839	1,787	9,148	-
Stock-Based Compensation	1,472	762.94	2,843	4,057	5,576
Other Operating Activities	-11,327	-1,510	-15,025	-39,488	-7,399
Change in Accounts Receivable	3,985	-3,921	-3,618	-231.5	897.49
Change in Other Net Operating Assets	-2,061	-1,519	1,030	-2,439	5,304
Operating Cash Flow	-21,139	-21,805	-9,117	-53,083	-51,945
Capital Expenditures	-64.41	-395.75	-45.22	-711.88	-1,615
Sale of Property, Plant & Equipment	-	8.87	323.21	240.02	-
Sale (Purchase) of Intangibles	-	-20	-	-7.03	-603.83
Other Investing Activities	-25.84	-132.64	-9.84	-	263.02
Investing Cash Flow	-90.25	-539.53	268.14	-478.89	-1,955
Long-Term Debt Issued	-	-	1,000	3,217	6,329
Total Debt Issued	-	-	1,000	3,217	6,329
Short-Term Debt Repaid	-925.12	-	-	-	-
Long-Term Debt Repaid	-1,843	-1,730	-1,625	-1,378	-774.99
Total Debt Repaid	-2,769	-1,730	-1,625	-1,378	-774.99
Net Debt Issued (Repaid)	-2,769	-1,730	-625.25	1,839	5,554
Issuance of Common Stock	7,382	37,980	-	147	3,014
Other Financing Activities	19,581	-0	-4.67	-0	-0
Financing Cash Flow	24,195	36,251	-629.92	1,986	67,692
Foreign Exchange Rate Adjustments	-95.36	465.06	-382.5	1,123	1,554
Net Cash Flow	2,870	14,372	-9,862	-50,454	15,346
Free Cash Flow	-21,203	-22,201	-9,163	-53,795	-53,560
Free Cash Flow Margin	-493.38%	-194.12%	-49.06%	-8810.69%	-3926.36%
Free Cash Flow Per Share	-492.40	-547.60	-244.19	-1668.57	-1627.16
Cash Interest Paid	396.9	400.26	454.26	510.72	247.05
Cash Income Tax Paid	-22.74	55.4	1,896	83.39	354.64
Levered Free Cash Flow	-27,099	-13,079	-28,427	-29,052	-14,039
Unlevered Free Cash Flow	-26,805	-12,695	-27,535	-27,203	-13,407
Change in Working Capital	1,925	-5,440	-2,587	-2,670	6,201

Source: S&P Global Market Intelligence. Standard template. Financial Sources.